Back to
CITADEL ADVISORS LLC
MYGN30 quarters
Position history for
CITADEL ADVISORS LLC's holdings in MYRIAD GENETICS INC
CITADEL ADVISORS LLC holds 1.5M shares of MYGN (MYRIAD GENETICS INC), worth $8.8M as of 2026-Q2. The position was increased (+238.5% shares). MYGN represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$8.8M
Current Shares
1.5M
Total Value Change
-$43,665
Total Shares Change
+1.2M
Quarter-by-Quarter History
Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC